Premium
METHICILLIN‐RESISTANT STAPHYLOCOCCUS AUREUS —AN OVERVIEW
Author(s) -
Eadon H. J.,
Pinney R. J.
Publication year - 1991
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/j.1365-2710.1991.tb00335.x
Subject(s) - staphylococcus aureus , methicillin resistant staphylococcus aureus , medicine , intensive care medicine , staphylococcal infections , antibiotics , organism , meticillin , infection control , microbiology and biotechnology , micrococcaceae , antibacterial agent , biology , bacteria , paleontology , genetics
Summary Methicillin‐resistant strains of Staphylococcus aureus (MRSA) cause life‐threatening infections, but they are no more pathogenic than methicillinsensitive strains. Difficulties occur because of incorrect or missed identification of MRSA, and hence inappropriate or ineffective treatment of infections. Therapeutic options are severely limited and the increasing spectrum of resistance in MRSA is worrying. However, new methods of detection and new agents for treatment are being developed in response to the challenge of MRSA. Whilst the organism is a problem and control measures are necessary to contain its spread, the outlook is not bleak. In the medium term, the development of new, effective anti‐MRSA agents should prevent the threat of MRSA becoming any greater in the field of hospital infection control.